Development and validation of a targeted gene sequencing panel for application to disparate cancers (2024)

McCabe, Mark J., Gauthier, Marie Emilie A., Chan, Chia Ling, Thompson, Tanya J., De Sousa, Sunita M.C., Puttick, Clare, Grady, John P., Gayevskiy, Velimir, Tao, Jiang, Ying, Kevin, Cipponi, Arcadi, Deng, Niantao, Swarbrick, Alex, Thomas, Melissa L., Lord, Reginald V., Johns, Amber L., Kohonen-Corish, Maija, O’Toole, Sandra A., Clark, Jonathan, Mueller, Simon A., Gupta, Ruta, McCormack, Ann I., Dinger, Marcel E., Cowley, Mark J., Aghmesheh, Morteza, Amor, David, Andrews, Lesley, Antill, Yoland, Armitage, Shane, Arnold, Leanne, Balleine, Rosemary, Bastick, Patti, Beesley, Jonathan, Beilby, John, Bennett, Ian, Blackburn, Anneke, Bogwitz, Michael, Botes, Leon, Brennan, Meagan, Brown, Melissa, Buckley, Michael, Burgess, Matthew, Burke, Jo, Butow, Phyllis, Caldon, Liz, Callen, David, Campbell, Ian, Chauhan, Deepa, Chauhan, Manisha, Chenevix-Trench, Georgia, Christian, Alice, Clarke, Christine, Cohen, Paul, Colley, Alison, Crook, Ashley, Cui, James, Culling, Bronwyn, Cummings, Margaret, Dawson, Sarah Jane, deFazio, Anna, Delatycki, Martin, Dickson, Rebecca, Dixon, Joanne, Dobrovic, Alexander, Dudding, Tracy, Edkins, Ted, Edwards, Stacey, Eisenbruch, Maurice, Farshid, Gelareh, Fellows, Andrew, Fenton, Georgina, Field, Michael, Flanagan, James, Fong, Peter, Forrest, Laura, Fox, Stephen, French, Juliet, Friedlander, Michael, Gaff, Clara, Ortega, Davi Gallego, Gattas, Mike, George, Peter, Giles, Graham, Gill, Grantley, Greening, Sian, Haan, Eric, Harris, Marion, Hart, Stewart, Hayward, Nick, Heiniger, Louise, Hopper, John, Hunt, Clare, James, Paul, Jenkins, Mark, Kefford, Rick, Kidd, Alexa, Kirk, Judy, Koehler, Jessica, Kollias, James, Lakhani, Sunil, Lindeman, Geoff, Lipton, Lara, Lobb, Liz, Mann, Graham, Marsh, Deborah, McLachaln, Sue Ann, Meiser, Bettina, Milne, Roger, Nightingale, Sophie, O’Connell, Shona, O’Sullivan, Sarah, Pachter, Nick, Patterson, Briony, Phillips, Kelly, Pieper, Ellen, Rickard, Edwina, Robinson, Bridget, Saleh, Mona, Salisbury, Elizabeth, Sambrook, Joe, Saunders, Christobel, Saunus, Jodi, Scott, Elizabeth, Scott, Clare, Scott, Rodney, Sexton, Adrienne, Shelling, Andrew, Simpson, Peter, Southey, Melissa, Spurdle, Amanda, Taylor, Jessica, Thorne, Heather, Trainer, Alison, Tucker, Kathy, Visvader, Jane, Walker, Logan, Williams, Rachael, Winship, Ingrid, Young, Mary Anne, & other, and(2019)Development and validation of a targeted gene sequencing panel for application to disparate cancers.Scientific Reports, 9, Article number: 17052.

Open access copy at publisher website

Description

Next generation sequencing has revolutionised genomic studies of cancer, having facilitated the development of precision oncology treatments based on a tumour’s molecular profile. We aimed to develop a targeted gene sequencing panel for application to disparate cancer types with particular focus on tumours of the head and neck, plus test for utility in liquid biopsy. The final panel designed through Roche/Nimblegen combined 451 cancer-associated genes (2.01 Mb target region). 136 patient DNA samples were collected for performance and application testing. Panel sensitivity and precision were measured using well-characterised DNA controls (n = 47), and specificity by Sanger sequencing of the Aryl Hydrocarbon Receptor Interacting Protein (AIP) gene in 89 patients. Assessment of liquid biopsy application employed a pool of synthetic circulating tumour DNA (ctDNA). Library preparation and sequencing were conducted on Illumina-based platforms prior to analysis with our accredited (ISO15189) bioinformatics pipeline. We achieved a mean coverage of 395x, with sensitivity and specificity of >99% and precision of >97%. Liquid biopsy revealed detection to 1.25% variant allele frequency. Application to head and neck tumours/cancers resulted in detection of mutations aligned to published databases. In conclusion, we have developed an analytically-validated panel for application to cancers of disparate types with utility in liquid biopsy.

Impact and interest:

15 citations in Scopus

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

More statistics...

ID Code: 248628
Item Type: Contribution to Journal (Journal Article)
Refereed: Yes
ORCID iD:
Gauthier, Marie Emilie A.orcid.org/0000-0002-5256-9165
Measurements or Duration: 16 pages
DOI: 10.1038/s41598-019-52000-3
ISSN: 2045-2322
Pure ID: 169067949
Funding Information: We would like to thank Mr. Ben Lundie at Garvan Institute of Medical Research for the provision of the four Coriell Institute samples. We would also like to thank the Kinghorn Centre for Clinical Genomics for technical assistance, and acknowledge the generous support of ICAP and the family and friends of Michael O’Sullivan, both donors to molecular cancer research at RPAH, Sydney. Finally, research was undertaken with assistance and services from the National Computational Infrastructure, which is supported by the Australian Government. This work was supported by a Cancer Institute NSW Early Career Fellowship (Grant Number 13/ECF/1-46), Cancer Institute NSW Career Development Fellowship (Grant Number 2019/CDF004), NSW Health Early-Mid Career Fellowship, Cancer Council NSW (Grant Number RG 15–19), Therapeutic Innovation Australia, and philanthropic donations from the Kinghorn Foundation.
Copyright Owner: 2019 The Authors
Copyright Statement: This work is covered by copyright. Unless the document is being made available under a Creative Commons Licence, you must assume that re-use is limited to personal use and that permission from the copyright owner must be obtained for all other uses. If the document is available under a Creative Commons License (or other specified license) then refer to the Licence for details of permitted re-use. It is a condition of access that users recognise and abide by the legal requirements associated with these rights. If you believe that this work infringes copyright please provide details by email to qut.copyright@qut.edu.au
Deposited On: 21 May 2024 02:29
Last Modified: 21 May 2024 21:16

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page

Development and validation of a targeted gene sequencing panel for application to disparate cancers (2024)

References

Top Articles
Latest Posts
Article information

Author: Kareem Mueller DO

Last Updated:

Views: 6667

Rating: 4.6 / 5 (46 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Kareem Mueller DO

Birthday: 1997-01-04

Address: Apt. 156 12935 Runolfsdottir Mission, Greenfort, MN 74384-6749

Phone: +16704982844747

Job: Corporate Administration Planner

Hobby: Mountain biking, Jewelry making, Stone skipping, Lacemaking, Knife making, Scrapbooking, Letterboxing

Introduction: My name is Kareem Mueller DO, I am a vivacious, super, thoughtful, excited, handsome, beautiful, combative person who loves writing and wants to share my knowledge and understanding with you.